Some diabetes drugs called GLP-1 agonists might help ease depression in people, based on early studies — but we’re not sure yet because the research has some flaws.

55

Pro

0

Against

Evidence from Studies

Supporting (1)

55

Community contributions welcome

55

The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.

Systematic Review With Meta-Analysis

Human

2024 Jan

The study looked at whether diabetes drugs called GLP-1 receptor agonists help with depression, and found they might—just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.

Score: 55

DOI: 10.1016/j.jagp.2023.08.010

Similar Assertions

Some diabetes drugs called GLP-1 agonists might help with depression symptoms, based on a few studies — but the results aren't clear-cut and more research is needed.

20

0

92%

So far, only one in three studies has found that diabetes drugs called GLP-1 agonists might help with depression, so the proof isn't strong or clear yet.

20

0

91%

People with type 2 diabetes or obesity who take GLP-1 drugs like semaglutide might be less likely to develop depression or anxiety.

50

0

85%

People with type 2 diabetes who take GLP-1 drugs like Ozempic might feel a little better emotionally, but the mood boost is small and doesn’t show up in every study.

20

0

83%

Taking diabetes drugs called GLP-1 receptor agonists might slightly improve mood in people, whether or not they have diabetes, based on depression score changes in studies.

55

0

77%